2008-2017年全球学校接种常规推荐疫苗及学校查验接种状态机会概述
研究基于WHO-UNICEF联合报告表数据,描述2008至2017年各国学校接种疫苗(SBV)的实施情况,包括2017年目标年龄组和疫苗种类。报告在学校接种至少一剂常规推荐疫苗的国家比例从2008年58%(95/163)升至2017年60%(108/181)。在93个有净小学入学率和家庭接种记录(HBR)拥有率数据的国家中,52国(56%)两项指标均≥80%,其中33国(63%)已使用SBV。
要点
- 2008至2017年报告学校接种至少一剂常规推荐疫苗的国家比例从58%升至60%。
- 2017年学校接种最常见抗原为破伤风(94国)、白喉(89国)和人乳头瘤病毒(52国)。
- 52国净小学入学率和12-23月龄儿童HBR拥有率均≥80%,其中33国已使用学校接种。
核心结论
- 随着针对学龄儿童的新疫苗和加强剂次增多,实施学校接种和在校查验学生接种记录可能有助于提高接种覆盖率;但需额外数据评估全球在校查验接种状态的普及程度并识别促进该策略优化实施的因素。
研究设计与样本
- 基于世界卫生组织(WHO)-联合国儿童基金会(UNICEF)联合报告表(JRF)年度报告数据的全球描述性总结,分析2008至2017年各国学校接种实施情况,并将国家层面的净小学入学率和家庭接种记录(HBR)拥有率与JRF数据链接。
主要发现
- 报告在学校接种至少一剂常规推荐疫苗的国家比例从2008年58%(95/163)升至2017年60%(108/181)。
- 2017年新增报告使用学校接种的13个国家属于当年JRF学校接种数据不可用的31个国家之列。
- 2017年学校接种最常见抗原为破伤风(94国)、白喉(89国)和人乳头瘤病毒(52国)。
- 在93个有净小学入学率和HBR拥有率数据的国家中,52国(56%)两项指标均≥80%,其中33国(63%)使用学校接种。
关键数值与推荐
- 学校接种定义为在学校环境中接种至少一剂常规推荐疫苗。
- 高潜力实施在校查验接种记录的国家定义为净小学入学率≥80%且12-23月龄儿童曾拥有HBR比例≥80%。
临床怎么用
- 对于尚未实施学校接种的33个高潜力国家,代表可在小学入学时或小学期间引入常规查验接种状态的机会。
- 实施学校接种和在校查验学生接种记录可能有助于提高接种覆盖率。
局限性
- 需要额外数据评估全球在校查验接种状态的普及程度并识别促进该策略优化实施的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
School-based vaccination (SBV) and checking students' vaccination records at school have the potential to optimize vaccination coverage among school-aged children. The primary aim of this paper is to describe adoption of SBV by countries from 2008 to 2017, including target age groups and vaccines delivered in 2017, as reported annually through the World Health Organization (WHO)-United Nations Children's fund (UNICEF) Joint Reporting Form (JRF). Expanding upon previous analyses, country-specific rates of primary school enrollment and home-based record (HBR) ownership were linked to the WHO-UNICEF JRF data, to identify countries with high potential to implement vaccination record checks at school. The proportion of countries reporting delivery of at least one routinely recommended vaccine dose in school settings increased from 95 (of 163 reporting; 58%) in 2008 to 108 (of 181 reporting; 60%) in 2017. The 13 additional countries that reported using SBV in 2017 were among 31 countries for which SBV data from the JRF were unavailable in 2017. The most common antigens delivered through SBV in 2017 were tetanus (94 countries), diphtheria (89 countries), and human papillomavirus (52 countries). Among 93 countries with data available for net primary school enrollment and HBR ownership, 52 (56%) countries had both ≥80% net primary school enrollment and ≥80% of children aged 12-23 months ever owning an HBR; 33 (63%) of these used SBV. If not already doing so, these 33 countries represent an opportunity to introduce routine checking of vaccination status at entry to, or during primary school. With the growing number of new vaccines and booster doses of childhood vaccines targeting school-age children, implementation of SBV and checking of student vaccination records at school may help improve vaccination coverage; however, additional data are needed to assess global prevalence of checking vaccination status at school and to identify factors facilitating optimal implementation of this strategy.
引用
- Feldstein LR, Fox G, Shefer A, et al. School-based delivery of routinely recommended vaccines and opportunities to check vaccination status at school, a global summary, 2008-2017. Vaccine. 2019. PMID: 31679861. doi:10.1016/j.vaccine.2019.10.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。